Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Arcuri, Leonardo Javier  [Clear All Filters]
2024
Arcuri LJavier. Re: Prophylactic versus preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study. Bone Marrow Transplant. 2024.
2023
Arcuri LJavier, Ribeiro AAlice Feit, Hamerschlak N, Kerbauy MNassif. Posttransplant cyclophosphamide beyond haploidentical transplantation. Ann Hematol. 2023.
2022
Arcuri LJavier, Kerbauy MNassif, Kerbauy LNassif, Santos FPires de S, Ribeiro AAlice Feit, Hamerschlak N. ATG in HLA-matched, peripheral blood, hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome: a secondary analysis of a CIBMTR database. Transplant Cell Ther. 2022.
2020
Arcuri LJavier, Nabhan SKanaan, Loth G, Atta EHallack, Oliveira M, Nichele S, Araujo Rde Castro, Bonfim C. A case series of post-transplant cyclophosphamide in unrelated donor hematopoietic transplantation for aplastic anemia. Biol Blood Marrow Transplant. 2020.
Tavares Rde Cássia, Bonfim CSales, Seber A, Lermontov SPereira, Coulturato V, Zecchin VGottardell, Ribeiro L, Fernandes JFolloni, Daudt LEsteves, Grecco CS, et al. Hematopoietic cell transplantation in pediatric patients with acute leukemias or myelodysplastic syndrome using unrelated adult or umbilical cord blood donors in Brazil. Pediatr Transplant. 2020:e13789.
Arcuri LJavier, Schirmer M, Colares M, Maradei S, Tavares R, Moreira MCláudia R, Araujo Rde Castro, Lerner D, Pacheco AGuilherme. Impact of anti-CMV IgG titers and CD34 count prior to hematopoietic stem cell transplantation from alternative donors. Biol Blood Marrow Transplant. 2020.
Arcuri LJavier, Nabhan SKanaan, Cunha R, Nichele S, Ribeiro AAlice Feit, Fernandes JFolloni, Daudt LEsteves, Rodrigues ALuiza Melo, Arrais-Rodrigues C, Seber A, et al. Impact of CD34 cell dose and conditioning regimen on outcomes after Haploidentical donor hematopoietic stem cell transplantation with post-transplant cyclophosphamide for relapsed/refractory severe aplastic anemia: Haploidentical HCT with PTCy for SAA. Biol Blood Marrow Transplant. 2020.
Fernandes JFolloni, Nichele S, Arcuri LJavier, Ribeiro L, Netto GZamperlini, Loth G, Rodrigues ALuiza Melo, Kuwahara C, Koliski A, Trennepohl J, et al. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases. Biol Blood Marrow Transplant. 2020.
2019
Arcuri LJavier, Aguiar MTayla Mesq, Ribeiro AAlice Feit, Pacheco AGuilherme. Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Biol Blood Marrow Transplant. 2019.